Mechanical prostheses were associated with a significantly higher rate of major bleeding at 15 years compared with bioprostheses: 13.0 percent for the mechanical
prosthesis group vs. 6.6 percent for the bioprosthesis group.
Bioprostheses were associated with a significantly higher rate of aortic valve reoperation than mechanical prostheses: the cumulative incidence of aortic valve reoperation at 15 years was 12.1 percent in the bioprosthesis group and 6.9 percent in the mechanical
prosthesis group.
Fifteen - year survival was 60.6 percent in the bioprosthesis group compared with 62.1 percent in the mechanical
prosthesis group.
The cumulative incidence of stroke at l5 years after mitral valve replacement was significantly higher in the mechanical
prosthesis group (14.0 percent) compared with the bioprosthesis group (6.8 percent), as was the cumulative incidence of bleeding events (14.9 percent vs. 9.0 percent).
The cumulative incidence of mitral valve reoperation at 15 years was significantly lower in the mechanical
prosthesis group (5.0 percent) compared with the bioprosthesis group (11.1 percent).
«You can't underestimate the scope of the problem, particularly as the population gets older,» says James Morrison, a physiologist and principal investigator in the Retinal
Prosthesis Group at the University of Glasgow's Institute of Biomedical and Life Sciences.
Not exact matches
For the Italian
group, and for all others involved in research on advanced
prostheses, the method provides a new tool for exploring the sensations the
prostheses can provide.
Rehm is now part of an IAAF working
group studying
prosthesis use in athletic competition, in hopes of competing in the 2017 IAAF World Championships.
«We can confidently say that this type of
prosthesis is a viable choice and the new infection classification system, developed by the Osseointegrated
Group of Australia, provides an effective tool for the use in patient selection as well as infection management.»
Second Sight's retinal
prosthesis is currently approved only for patients with inherited retinal disorders (IRD), formerly known as retinitis pigmentosa, a
group of genetic diseases characterized by a loss of photoreceptors.
He has extensive experience of «
group litigation» and product liability claims in relation to medical devices, such as breast implants, hip
prostheses, and mesh.
Durable medical equipment — artificial limb and scalp hair
prostheses — for individual and
group plans
Durable medical equipment — scalp - hair
prostheses for alopecia areata - for individual and
group plans, HMO
The book contains such useful information as lists of questions to ask your doctor, times and dates of support
groups, and where to get a wig or a
prosthesis.